A multicentre roadmap to restart elective cardiac surgery after COVID-19 peak in an Italian epicenter

Fabrizio Rosati1, Claudio Muneretto1, Massimo Baudo1

  • 1Division of Cardiac Surgery, Spedali Civili di Brescia, University of Brescia, Brescia, Italy.

Insights

Restarting elective cardiac surgery during COVID-19 is feasible with a clean path protocol. Mild lung inflammation from prior coronavirus disease 2019 (COVID-19) infection does not necessitate delaying surgery.

Area of Science:

  • Cardiology
  • Infectious Diseases
  • Thoracic Surgery
  • Public Health

Background:

  • Resuming elective surgeries during the COVID-19 pandemic required careful planning.
  • Hospitals needed to manage both COVID-19 patients and non-COVID-19 surgical candidates.
  • Establishing a
  • clean path
  • protocol was crucial for patient safety.

Purpose of the Study:

  • To assess the safety and feasibility of restarting elective cardiac surgery during the COVID-19 pandemic.
  • To evaluate the impact of prior COVID-19 infection on surgical outcomes.
  • To determine the effectiveness of a multi-step screening process for surgical candidates.

Main Methods:

  • A four-step screening roadmap was implemented for 259 elective cardiac surgery patients.
  • Screening included questionnaires, nasopharyngeal swabs, and CT scans with CO-RADS scoring.
  • Data were collected from May to July 2020 across three surgical centers.

Main Results:

  • Only 0.8% of patients tested positive for COVID-19 pre-operatively.
  • 6.3% of chest CT scans showed mild to moderate lung inflammation (CO-RADS 2-4), which did not delay surgery.
  • Perioperative mortality was 1.15%, with no reported periprocedural COVID-19 contagion or rehospitalizations.

Conclusions:

  • A structured screening protocol enables the safe resumption of elective cardiac surgery during a pandemic.
  • Mild CT findings of prior COVID-19 pneumonia should not postpone necessary surgical interventions.
  • Age and cardiopulmonary bypass time were identified as risk factors for pulmonary complications.
Abstract

Related Concept Videos

Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
69
Cardiopulmonary Resuscitation IV: Pharmacological Management01:25

Cardiopulmonary Resuscitation IV: Pharmacological Management

Pharmacologic intervention is crucial in treating cardiac arrest patients during ACLS or Advanced Cardiovascular Life Support. The ACLS algorithms guide the administration of specific drugs based on the patient's cardiac arrest rhythm, which includes pulseless ventricular tachycardia (VT), ventricular fibrillation (VF), asystole, and pulseless electrical activity (PEA).EpinephrineIndication: Epinephrine is the first-line drug for all cardiac arrest rhythms.Mechanism of Action: Epinephrine...
161
Cardiomyopathy VII: Pre and Post Operative Nursing Management01:28

Cardiomyopathy VII: Pre and Post Operative Nursing Management

Patients with hypertrophic cardiomyopathy (HCM) and left ventricular outflow tract (LVOT) obstruction who remain symptomatic despite optimal medical therapy may undergo a septal myectomy (Morrow procedure). This procedure involves excising a portion of the hypertrophied septum below the aortic valve using a heart-lung machine to improve blood flow through the LVOT. Effective preoperative and postoperative nursing management ensures successful patient outcomes, minimizes complications, and...
82